• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment.

作者信息

Knatterud G L, Klimt C R, Levin M E, Jacobson M E, Goldner M G

出版信息

JAMA. 1978 Jul 7;240(1):37-42.

PMID:351218
Abstract

The University Group Diabetes Program is a long-term prospective clinical trial designed to evaluate the effects of various hypoglycemic agents on vascular complications in patients with asymptomatic adult-onset diabetes. Mortality and blood glucose levels were determined as well as certain nonfatal events for patients assigned to diet alone or to either of two insulin treatment regimens. Lower levels of blood glucose with mean values close to normoglycemia were achieved in the treatment group in which the insulin dosage was adjusted to achieve normoglycemia compared with the levels achieved in patients treated with diet alone or with a fixed dose of insulin. In spite of differences in blood glucose levels among the treatment groups, there were only minor differences in the occurrence of fatal or nonfatal events.

摘要

相似文献

1
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment.
JAMA. 1978 Jul 7;240(1):37-42.
2
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
Diabetes. 1982 Nov;31 Suppl 5:1-81.
3
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.
JAMA. 1971 Nov;218(9):1400-10.
4
A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.一项关于降糖药物对成年发病型糖尿病患者血管并发症影响的研究。II. 死亡率结果。
Diabetes. 1970;19:Suppl:789-830.
5
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
JAMA. 1971 Aug 9;217(6):777-84.
6
Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.强化与适度血糖控制对糖尿病冠状动脉旁路移植术患者临床结局的影响。
Ann Surg. 2011 Sep;254(3):458-63; discussion 463-4. doi: 10.1097/SLA.0b013e31822c5d78.
7
[Do oral antidiabetics play a part in the cardiovascular mortality of diabetics? Apropos of the University Group Diabetes Program report and the controversies it has raised].
Presse Med (1893). 1971 Dec 11;79(53):2437-44.
8
[Differential therapy using oral antidiabetics].[使用口服抗糖尿病药物的差异疗法]
Internist (Berl). 1971 Nov;12(11):468-75.
9
Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.心肌梗死后强化基于胰岛素的血糖控制:随机糖尿病胰岛素葡萄糖输注治疗急性心肌梗死(DIGAMI 1)试验 20 年随访期间的死亡率。
Lancet Diabetes Endocrinol. 2014 Aug;2(8):627-33. doi: 10.1016/S2213-8587(14)70088-9. Epub 2014 May 13.
10
Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy.未诊断的无症状低血糖:妊娠期糖尿病孕妇的饮食、胰岛素和格列本脲治疗
Obstet Gynecol. 2004 Jul;104(1):88-93. doi: 10.1097/01.AOG.0000129239.82126.a1.

引用本文的文献

1
How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool.用于一般实践中 2 型糖尿病患者糖化血红蛋白水平控制推荐的随机试验有多么实用:PRECIS II 工具的应用。
Trials. 2020 Mar 19;21(1):281. doi: 10.1186/s13063-020-4215-5.
2
The trials and tribulations of the University Group Diabetes Program 1: the trial and the controversies.大学组糖尿病项目的艰难历程1:试验与争议
J R Soc Med. 2019 Nov;112(11):476-482. doi: 10.1177/0141076819884869.
3
Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.
年龄相关的葡萄糖代谢变化、高血糖和心血管风险。
Circ Res. 2018 Sep 14;123(7):886-904. doi: 10.1161/CIRCRESAHA.118.312806.
4
Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment.糖尿病患者的心力衰竭风险和主要心血管事件:非胰岛素类降糖药物治疗组内差异概述。
Heart Fail Rev. 2018 May;23(3):469-479. doi: 10.1007/s10741-017-9667-7.
5
Cardiovascular disease and diabetes: modifying risk factors other than glucose control.心血管疾病与糖尿病:调整血糖控制以外的风险因素。
Ochsner J. 2001 Jul;3(3):132-7.
6
Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.强化血糖控制对 2 型糖尿病患者的影响:随机临床试验的系统评价和试验序贯分析。
BMJ. 2011 Nov 24;343:d6898. doi: 10.1136/bmj.d6898.
7
Insulin: potential negative consequences of early routine use in patients with type 2 diabetes.胰岛素:2型糖尿病患者早期常规使用的潜在负面后果。
Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S225-30. doi: 10.2337/dc11-s225.
8
Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy.二甲双胍和磺酰脲类药物在 2 型糖尿病中的应用与多种结局相关:意大利基于人群的队列研究。
Eur J Clin Pharmacol. 2011 Mar;67(3):289-99. doi: 10.1007/s00228-010-0939-6. Epub 2010 Nov 19.
9
Glucose control and cardiovascular disease: is it important? No.血糖控制与心血管疾病:重要吗?不重要。
Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S334-6. doi: 10.2337/dc09-S334.
10
Pregnancy glycemia to vascular risk: nonglycemic diabetes?妊娠血糖与血管风险:非血糖性糖尿病?
CMAJ. 2009 Sep 15;181(6-7):361-2. doi: 10.1503/cmaj.091396. Epub 2009 Aug 24.